NEW AZOLE COMPOUNDS - VIBUNAZOLE (BAY N7133) AND BAY L9139, COMPARED WITH KETOCONAZOLE IN THE THERAPY OF SYSTEMIC CANDIDOSIS AND IN PHARMACOKINETIC STUDIES, IN MICE

被引：8

作者：

LEFLER, E

STEVENS, DA

机构：

[1] SANTA CLARA VALLEY MED CTR,DEPT PATHOL,CLIN MICROBIOL LAB,SAN JOSE,CA 95128

[2] INST MED RES,SAN JOSE,CA 95128

[3] STANFORD UNIV,MED CTR,SCH MED,STANFORD,CA 94305

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1985年 / 15卷 / 01期

关键词：

D O I：

10.1093/jac/15.1.69

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：69 / 75

页数：7

共 8 条

[1] CLOTRIMAZOLE - NEW DRUG FOR SYSTEMIC MYCOSES [J].

BENNETT, JE .

ANNALS OF INTERNAL MEDICINE, 1970, 73 (04) :653-+

[2] DISPOSITION OF KETOCONAZOLE, AN ORAL ANTIFUNGAL, IN HUMANS [J].

BRASS, C ;

GALGIANI, JN ;

BLASCHKE, TF ;

DEFELICE, R ;

OREILLY, RA ;

STEVENS, DA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (01) :151-158

[3]

FROMTLING RA, 1983, SABOURAUDIA, V21, P179

[4] ANTIMICROBIAL SUSCEPTIBILITY TESTING OF YEASTS - TURBIDIMETRIC TECHNIQUE INDEPENDENT OF INOCULUM SIZE [J].

GALGIANI, JN ;

STEVENS, DA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1976, 10 (04) :721-726

[5]

HARVEY RP, 1980, REV INFECT DIS, V2, P559

[6] KETOCONAZOLE - A REVIEW OF ITS THERAPEUTIC EFFICACY IN SUPERFICIAL AND SYSTEMIC FUNGAL-INFECTIONS [J].

HEEL, RC ;

BROGDEN, RN ;

CARMINE, A ;

MORLEY, PA ;

SPEIGHT, TM ;

AVERY, GS .

DRUGS, 1982, 23 (1-2) :1-36

[7]

RITTER W, 1983, 13TH P INT C CHEM 20, P37

[8] CORRELATION OF INVITRO SUSCEPTIBILITY TEST-RESULTS WITH INVIVO RESPONSE - FLUCYTOSINE THERAPY IN A SYSTEMIC CANDIDIASIS MODEL [J].

STILLER, RL ;

BENNETT, JE ;

SCHOLER, HJ ;

WALL, M ;

POLAK, A ;

STEVENS, DA .

JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (06) :1070-1077

← 1 →